JANE STREET GROUP, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 173 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$927,152
-49.6%
47,693
-26.5%
0.00%
-100.0%
Q1 2023$1,840,560
+193.6%
64,877
+202.5%
0.00%
Q4 2022$626,896
+11.7%
21,447
+69.9%
0.00%
Q2 2022$561,000
+21.4%
12,620
+35.1%
0.00%
Q1 2022$462,000
+18.2%
9,342
+21.5%
0.00%
Q4 2021$391,000
+32.5%
7,687
+45.4%
0.00%
Q3 2021$295,000
-19.8%
5,288
-33.1%
0.00%
Q4 2020$368,000
-4.9%
7,900
-13.3%
0.00%
Q3 2020$387,000
+82.5%
9,114
+126.7%
0.00%
-100.0%
Q1 2018$212,000
-12.4%
4,021
+30.8%
0.00%0.0%
Q2 2017$242,000
+10.0%
3,073
+15.8%
0.00%0.0%
Q1 2017$220,000
-37.7%
2,653
-70.8%
0.00%
-50.0%
Q2 2016$353,000
-56.7%
9,100
-54.8%
0.00%
-50.0%
Q1 2016$815,000
+64.3%
20,112
+200.2%
0.00%
+33.3%
Q3 2015$496,000
+15.1%
6,699
+25.8%
0.00%0.0%
Q2 2015$431,000
+26.8%
5,327
-34.4%
0.00%0.0%
Q1 2015$340,0008,1250.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders